Spectrum Pharmaceuticals is owned and operated as a wholly-owned subsidiary of Assertio Holdings, Inc. Following the completion of their strategic corporate acquisition, Spectrum was fully integrated into Assertio's commercial infrastructure, combining operational teams, research initiatives, and pharmaceutical product portfolios under the parent corporation's overarching governance and public market structure.